stem cell research

(via Flickr/breahn)

A lawsuit has been filed that challenges the creation of a new fund to offer state incentives to science or technology companies.

The Missouri Roundtable for Life and Missouri Right to Life said Thursday the new fund should be void.

Legislators created the Missouri Science and Innovation Reinvestment Act this year during a special legislative session.

(Marshall Griffin/St. Louis Public Radio)

Missouri lawmakers have quit working this week without agreeing on the details of a bill overhauling
Missouri's tax credits and business incentives that had been touted as the marquee issue of a special session that began Sept. 6. There seems to be little chance of resolving the stalemate, but the two chambers did agree to keep
the special session going in case a compromise can be reached later.

Our earlier story:

(Wikimedia Commons/United States Senate)

A Chicago-based scientist says he's grateful to U.S. Sen. Mark Kirk for siding with legislation that backs stem cell research.

Kirk on Monday called for congressional action to codify an executive order on the research issued by President Barack Obama in 2009.

Dr. John Kessler directs a stem cell research institute at Northwestern University Feinberg School of Medicine.

A federal judge's ruling striking down the Obama administration's policy on embryonic stem cell research could result in an immediate halt for now in this kind of medical work in Missouri and nationally, according to some local and national proponents of the research.

That view was reinforced late yesterday by news that the National Institutes of Health has imposed a nationwide freeze on grants in the pipeline. That decision could affect research underway at both Washington University and the University of Missouri at Columbia.